You may find more updates here.
Selected research publications on HCQ protocol
- R. Derwand, M. Scholz, “Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today’s battle against COVID-19?”, Medical Hypotheses 142 (2020), 109815
- Risch, Harvey A, “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis”, American Journal of Epidemiology (2020), accepted
- Shittu, M., Afolami, O. (2020). Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives – A better synergy for future COVID-19 clinical trials. Le infezioni in medicina 28 (2), 192-197.
- Scholz, M.; Derwand, R.; Zelenko, V. “COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study”. Preprints 2020, 2020070025 (doi: 10.20944/preprints202007.0025.v1).
- Samia Arshad, Paul Kilgore, Zohra S. Chaudhry, Gordon Jacobsen, Dee Dee Wang, Kylie Huitsing, Indira Brar, George J. Alangaden, Mayur S. Ramesh, John E. McKinnon, William O’Neill, Marcus Zervos, Henry Ford COVID-19 Task Force (2020): “Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19”, International Journal of Infectious Diseases 97, 396-403
- Jean-Christophe Lagier, Matthieu Million, Philippe Gautret, Philippe Colson, Sebastien Cortaredona, Audrey Giraud-Gatineau, Stephane Honore, Jean-Yves Gaubert, Pierre-Edouard Fournier, Herve Tissot-Dupont, Eric Chabriere, Andreas Stein, Jean-Claude Deharo, Florence Fenollar, Jean-Marc Rolain, Yolande Obadia, Alexis Jacquier, Bernard La Scola, Philippe Brouqui, Michel Drancourt, Philippe Parola, Didier Raoult, Sophie Amrane, Camille Aubry, Matthieu Bardou, Cyril Berenger, Laurence Camoin-Jau, Nadim Cassir, Claire Decoster, Catherine Dhiver, Barbara Doudier, Sophie Edouard, Stephanie Gentile, Katell Guillon-Lorvellec, Marie Hocquart, Anthony Levasseur, Morgane Mailhe, Isabelle Ravaux, Magali Richez, Yanis Roussel, Piseth Seng, Christelle Tomei, Christine Zandotti: “Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis”, Travel Medicine and Infectious Disease (2020), 101791 (in press)
- Nijad Bakhshaliyev, Mahmut Uluganyan, Asim Enhos, Erdem Karacop, Ramazan Ozdemir, “The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients”, Journal of Electrocardiology, 2020 (in press)
- Peter A.McCullough, Ronan J.Kelly, Gaetano Ruocco, Edgar Lerma, James Tumlin, Kevin R.Wheelan, Nevin Katz, Norman E.Lepor, Kris Vijay, Harvey Carter, Bhupinder Singh, Sean P.McCullough, Brijesh K.Bhambi, Alberto Palazzuoli, Gaetano M.De Ferrari, Gregory P.Milligan, TaimurSafder, Kristen M.Tecson, Harvey A.Risch: “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection”, The American Journal of Medicine, in press.
Other selected research publications
- Grant, W.B.; Lahore, H.; McDonnell, S.L.; Baggerly, C.A.; French, C.B.; Aliano, J.L.; Bhattoa, H.P. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients 2020, 12, 988
- Colunga Biancatelli Ruben Manuel Luciano, Berrill Max, Catravas John D., Marik Paul E., “Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)”, Frontiers in Immunology 11 (2020), 1451
- Pagliaro, M.; Meneguzzo, F., “Hydroxychloroquine for the Treatment of COVID-19: Evidence, Possible Mode of Action and Industrial Supply of the Drug”. Preprints 2020, 2020040381 (doi: 10.20944/preprints202004.0381.v1).
- M. Gabriela M. Gomes, Rodrigo M. Corder, Jessica G. King, Kate E. Langwig, Caetano Souto-Maior, Jorge Carneiro, Guilherme Goncalves, Carlos Penha-Goncalves, Marcelo U. Ferreira, Ricardo Aguas, “Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold”, medRxiv 2020.04.27.20081893
- Wu, W.; Li, R.; Li, X.; He, J.; Jiang, S.; Liu, S.; Yang, J., “Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry”, Viruses 8 (2016), 6.
